Home  >  Products  >  COL9A1 (collagen, type IX, alpha 1 ) Blocking Peptide (the N terminal of COL9A1)(100ug)
COL9A1 (collagen, type IX, alpha 1 ) Blocking Peptide (the N terminal of COL9A1)(100ug)

COL9A1 (collagen, type IX, alpha 1 ) Blocking Peptide (the N terminal of COL9A1)(100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-COL9A1 Antibody (ARP60025_P050), made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Reactivities: Human
Presku: AAP60025
Size: 100ug
Weight: 62kDa
Gene: 1297
Format: Lyophilized powder
Target: This gene encodes one of the three alpha chains of type IX collagen, which is a minor (5-20%) collagen component of hyaline cartilage. Type IX collagen is usually found in tissues containing type II collagen, a fibrillar collagen. Studies in knockout mice have shown that synthesis of the alpha 1 chain is essential for assembly of type IX collagen molecules, a heterotrimeric molecule, and that lack of type IX collagen is associated with early onset osteoarthritis. Mutations in this gene are associated with osteoarthritis in humans, with multiple epiphyseal dysplasia, 6, a form of chondrodysplasia, and with Stickler syndrome, a disease characterized by ophthalmic, orofacial, articular, and auditory defects. Two transcript variants that encode different isoforms have been identified for this gene.
Alternative names: DJ149L1.1.2; EDM6; FLJ40263; MED
See Full Product Listings >